News & Analysis as of

Private Equity › Regulatory Reform › Private Equity Firms

White & Case LLP

M&A in Australia: Prospects for dealmaking looking up

White & Case LLP on

Australian M&A defied a slow growth environment to post a solid performance in 2024, while dealmakers are optimistic about the prospects for the year ahead - Australia’s economy continues to grow at a slow pace as...more

Robinson+Cole Health Law Diagnosis

Massachusetts Enhances Regulatory Oversight of Health Care Transactions on For-Profit and Private Equity Investments

Robinson+Cole Health Law Diagnosis on

Massachusetts has expanded regulatory oversight of health care transactions by imposing False Claims Act liability on health care owners and investors for changes including failure to disclose violations. On January 8, 2025,...more

Sheppard Mullin Richter & Hampton LLP

Massachusetts Expands Oversight of Private Equity Investment in Healthcare: Key Takeaways from House Bill 5159 Signed into Law by...

Sheppard Mullin Richter & Hampton LLP on

On January 8, 2025, Massachusetts Governor Maura Healey signed House Bill 5159 (“H.5159”) into law, marking a notable expansion of the regulation of private equity investments within the Massachusetts healthcare sector. The...more

A&O Shearman

Antitrust in focus March 2024

A&O Shearman on

This newsletter is a summary of the antitrust developments we think are most interesting to your business. Thomas Masterman, partner based in London, is our editor this month. He has selected: Out now: our latest global...more

4 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide